BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 9822741)

  • 1. Glial cell line-derived neurotrophic factor requires transforming growth factor-beta for exerting its full neurotrophic potential on peripheral and CNS neurons.
    Krieglstein K; Henheik P; Farkas L; Jaszai J; Galter D; Krohn K; Unsicker K
    J Neurosci; 1998 Dec; 18(23):9822-34. PubMed ID: 9822741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glial-cell-line-derived neurotrophic factor induces nerve fibre formation in primary cultures of adrenal chromaffin cells.
    Förander P; Broberger C; Strömberg I
    Cell Tissue Res; 2001 Jul; 305(1):43-51. PubMed ID: 11512671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGFbeta trophic factors differentially modulate motor axon outgrowth and protection from excitotoxicity.
    Ho TW; Bristol LA; Coccia C; Li Y; Milbrandt J; Johnson E; Jin L; Bar-Peled O; Griffin JW; Rothstein JD
    Exp Neurol; 2000 Feb; 161(2):664-75. PubMed ID: 10686085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glial cell line-derived neurotrophic factor rescues target-deprived sympathetic spinal cord neurons but requires transforming growth factor-beta as cofactor in vivo.
    Schober A; Hertel R; Arumäe U; Farkas L; Jaszai J; Krieglstein K; Saarma M; Unsicker K
    J Neurosci; 1999 Mar; 19(6):2008-15. PubMed ID: 10066254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of phosphatidylinositol 3-kinase activity blocks cellular differentiation mediated by glial cell line-derived neurotrophic factor in dopaminergic neurons.
    Pong K; Xu RY; Baron WF; Louis JC; Beck KD
    J Neurochem; 1998 Nov; 71(5):1912-9. PubMed ID: 9798915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptors of the glial cell line-derived neurotrophic factor family of neurotrophic factors signal cell survival through the phosphatidylinositol 3-kinase pathway in spinal cord motoneurons.
    Soler RM; Dolcet X; Encinas M; Egea J; Bayascas JR; Comella JX
    J Neurosci; 1999 Nov; 19(21):9160-9. PubMed ID: 10531419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of glial cell line-derived neurotrophic factor induced intracellular activity by K-252b on dopaminergic neurons.
    Pong K; Xu RY; Beck KD; Zhang TJ; Louis JC
    J Neurochem; 1997 Sep; 69(3):986-94. PubMed ID: 9282920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblast growth factor-2 requires glial-cell-line-derived neurotrophic factor for exerting its neuroprotective actions on glutamate-lesioned hippocampal neurons.
    Lenhard T; Schober A; Suter-Crazzolara C; Unsicker K
    Mol Cell Neurosci; 2002 Jun; 20(2):181-97. PubMed ID: 12093153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glial cell line-derived neurotrophic factor protects dopaminergic neurons from 6-hydroxydopamine toxicity in vitro.
    Eggert K; Schlegel J; Oertel W; Würz C; Krieg JC; Vedder H
    Neurosci Lett; 1999 Jul; 269(3):178-82. PubMed ID: 10454161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Other neurotrophic factors: glial cell line-derived neurotrophic factor (GDNF).
    Saarma M; Sariola H
    Microsc Res Tech; 1999 May 15-Jun 1; 45(4-5):292-302. PubMed ID: 10383122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of glial cell line-derived neurotrophic factor (GDNF) on dopaminergic neurons require concurrent activation of cAMP-dependent signaling pathways.
    Engele J; Franke B
    Cell Tissue Res; 1996 Nov; 286(2):235-40. PubMed ID: 8854892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of sympathetic neuron survival by synergistic action of NT3 and GDNF.
    Kobayashi M; Matsuoka I
    Neuroreport; 2000 Aug; 11(11):2541-5. PubMed ID: 10943719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor are required simultaneously for survival of dopaminergic primary sensory neurons in vivo.
    Erickson JT; Brosenitsch TA; Katz DM
    J Neurosci; 2001 Jan; 21(2):581-9. PubMed ID: 11160437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GDNF induces the calretinin phenotype in cultures of embryonic striatal neurons.
    Farkas LM; Suter-Crazzolara C; Unsicker K
    J Neurosci Res; 1997 Nov; 50(3):361-72. PubMed ID: 9364321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-beta 3, glial cell line-derived neurotrophic factor, and fibroblast growth factor-2, act in different manners to promote motoneuron survival in vitro.
    Gouin A; Bloch-Gallego E; Tanaka H; Rosenthal A; Henderson CE
    J Neurosci Res; 1996 Feb; 43(4):454-64. PubMed ID: 8699531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The survival-promoting effect of glial cell line-derived neurotrophic factor on axotomized corticospinal neurons in vivo is mediated by an endogenous brain-derived neurotrophic factor mechanism.
    Giehl KM; Schütte A; Mestres P; Yan Q
    J Neurosci; 1998 Sep; 18(18):7351-60. PubMed ID: 9736655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral expression and biological activities of GDNF, a new neurotrophic factor for avian and mammalian peripheral neurons.
    Trupp M; Rydén M; Jörnvall H; Funakoshi H; Timmusk T; Arenas E; Ibáñez CF
    J Cell Biol; 1995 Jul; 130(1):137-48. PubMed ID: 7790368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glial cell line-derived neurotrophic factor but not transforming growth factor beta 3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesion.
    Sauer H; Rosenblad C; Björklund A
    Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8935-9. PubMed ID: 7568047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGF-beta promotes survival on mesencephalic dopaminergic neurons in cooperation with Shh and FGF-8.
    Roussa E; Farkas LM; Krieglstein K
    Neurobiol Dis; 2004 Jul; 16(2):300-10. PubMed ID: 15193287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein from chromaffin granules promotes survival of mesencephalic dopaminergic neurons by an EGF-receptor ligand-mediated mechanism.
    Krieglstein K; Unsicker K
    J Neurosci Res; 1997 Apr; 48(1):18-30. PubMed ID: 9086178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.